Tata Global Beverages leads gainers in 'A' group

Havells India, Bata India, Aurobindo Pharma and Indiabulls Real Estate are among the other gainers

Tata Global Beverages surged 10.01% to Rs 107.75 after the company said it has entered into a 50:50 joint venture with Starbucks Coffee Company to open Starbucks cafés across India. The company made this announcement after market hours on Monday, 30 January 2012. Tata Global Beverages said that the 50:50 joint venture (JV) with Starbucks named TATA Starbucks will own and operate Starbucks cafés which will be branded as Starbucks Coffee "A Tata Alliance". The retail stores will be developed in cities across the country, beginning with stores in Delhi and Mumbai in calendar 2012. The stock topped the gainers in the BSE's 'A' group.




Havells India surged 8.23% to Rs 480 and was the second biggest gainer in 'A' group. The stock extended Monday's 3.42% surge after net profit rose 29.1% to Rs 78.88 crore on 29.7% rise in net sales to Rs 896.17 crore in Q3 December 2011 over Q3 December 2010. The result was announced during market hours on Monday, 30 January 2012.

Bata India advanced 7.35% to Rs 687.55 and was the third biggest gainer in 'A' group. During market hours today, 31 January 2012, the company reported 46.81% rise in net profit to Rs 30.42 crore on 26.80% rise in net sales to Rs 369.98 crore in Q3 December 2011 over Q3 December 2010.

Aurobindo Pharma gained 7.09% to Rs 114.80 and was fourth biggest gainer in 'A' group. The company will declare its Q3 results on 10 February 2012. The stock had outperformed the market over the past one month till 30 January 2012, gaining 25.90% compared with the Sensex's 9.11% rise. The scrip, however, underperformed the market in past one quarter, sliding 16.54% as against 5.29% decline in the Sensex.

Indiabulls Real Estate rose 6.84% to Rs 71.05 and was fifth biggest gainer in 'A' group. The stock had outperformed the market over the past one month till 30 January 2012, gaining 42.25% compared with the Sensex's 9.11% rise. The scrip had, however, outperformed the market in past one quarter, falling 10.20% as against 5.29% decline in the Sensex.